Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Patent CN111484524A details a novel C15 intermediate synthesis for vitamin A acetate, offering high yield, safety, and cost reduction for pharmaceutical manufacturers.
Novel catalytic method for Salidroside production. High yield, cost-effective, scalable supply chain solution for pharmaceutical and cosmetic industries.
Deep dive into enantioselective sulfoximine synthesis via iron-catalyzed oxidation. Offers cost reduction in agrochemical intermediate manufacturing and scalable supply solutions.
Patent CN111560005A details green synthesis of 2-thiopheneacetyl chloride offering high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN103360425A details a novel synthesis of Tenofovir Disoproxil Fumarate, offering higher purity and yield while eliminating toxic azeotropic agents for cost-effective manufacturing.
Patent CN101648978A details a novel PEG-catalyzed route for >99% purity hexaphenoxycyclotriphosphazene, offering significant cost reduction and supply chain reliability for specialty chemical manufacturers.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.
Patent CN1266145C reveals a novel ester-mediated synthesis of Δ9-THC, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing without heavy metal residues.
Advanced preparation method for olmesartan medoxomil intermediates using novel tetrazole protection. Reduces impurities and simplifies purification for API manufacturing.
Novel asymmetric 3,5-diarylmethylene-4-piperidones with anti-tumor activity. Efficient Claisen-Schmidt synthesis route ensures scalable production for pharma partners.
Patent CN111372914A discloses efficient halogenation routes for herbicide intermediates, offering scalable synthesis and cost-effective manufacturing strategies.
Patent CN115611800A reveals a green, two-step synthesis for 1,1-dimethyl-4,4'-bipyridine dichloride, offering significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN116375656B details a high-purity metconazole metabolite synthesis. Offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN109456249B details a metal-free, acid-catalyzed route to isatin derivatives using oxygen, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111004184A details a solvent-free chlorination process for 4 6-dichloropyrimidine offering high purity and reduced wastewater for supply chains.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Patent CN107935950B reveals a scalable synthesis for broad-spectrum antibacterial triazole derivatives, offering cost-effective solutions for API manufacturing.
Novel catalytic route for Ramelteon intermediate reduces by-products and enhances supply chain stability for pharmaceutical manufacturing partners globally.